Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00208195 · ClinicalTrials.gov registry record · Phase 4
Depakote ER Therapy for Mania Comorbid With Substance Abuse
A Phase 4 study, sponsored by Creighton University.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00208195 is a Phase 4 study that has completed, run by Creighton University. The registered enrollment target is 20 participants.
The verdict
NCT00208195, a Phase 4 study, has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to ascertain whether Depakote ER (Divalproex ER) has efficacy in the treatment of patients with bipolar disorder in the manic phase, who also have comorbid substance abuse diagnoses. It is proposed that Depakote ER will decrease scores on the Young Mania Rating Scale and the Substance Abuse Time Line Follow Back.
Interventions
- DRUG Divalproex ER
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-03 |
| Est. Completion | 2007-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00208195
The ClinicalTrials.gov registry entry for NCT00208195 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Divalproex ER is the first listed.
NCT00208195 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00208195 about?
NCT00208195 is a clinical study titled "Depakote ER Therapy for Mania Comorbid With Substance Abuse". The purpose of this study is to ascertain whether Depakote ER (Divalproex ER) has efficacy in the treatment of patients with bipolar disorder in the manic phase, who also have comorbid substance abuse diagnoses. It is proposed that Depakote ER will decrease scores on the Young Mania Rating Scale and...
What is the current status of trial NCT00208195?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2004-03. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00208195?
The interventions under investigation include: Divalproex ER (DRUG).
Who is sponsoring clinical trial NCT00208195?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.